(P-328) PrEP Utilization Patterns and Indications in a Cohort of HIV-Negative Individuals

Monday, October 20, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

KM

Kenneth H. Mayer, MD, MPH

Professor of Medicine
Harvard Medical School/Fenway Research Institute
Boston, MA, United States
RS

Rachel Scott, MD, MPH

MedStar Health Research Institute, Georgetown University
Washington, District of Columbia, United States
Aniruddha Hazra, MD (he/him/his)

Associate Professor of Medicine
University of Chicago
Chicago, IL, United States
Helen Koenig, MD, MPH

Professor of Medicine
Hospital of the University of Pennsylvania
Philadelphia, PA, United States
IM

Isobel McEwen, MS

Trio Health
Louisville, Colorado, United States
CN

Chris Nguyen, PharmD

Gilead Sciences, Inc.
Foster City, California, United States
KB

Kristin Baker, PA-C

Gilead Sciences, Inc
Foster City, California, United States
OO

Olayemi Oladapo, PharmD

Gilead Sciences, Inc
Foster City, California, United States
YT

Yenyen Tran, PharmD

Gilead Sciences, Inc
Foster City, California, United States
JG

Joshua Gruber, PhD MPH (he/him/his)

Director, HIV Global Medical Affairs
Gilead Sciences
Forest City, California, United States
BS

Brett Shannon, PhD

Gilead Sciences, Inc
Foster City, California, United States
JR

Janna Radtchenko, MBA

Senior Director, Analytics
Trio Health
Louisville, Colorado, United States